Clinical Trial Update: Adjunctive Cilostazol Versus High Maintenance-dose Clopidogrel According to Cytochrome 2C19 Polymorphism [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing adjunctive cilostazol to high maintenance-dose clopidogrel in coronary artery disease patients undergoing percutaneous coronary…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• Cilostazol (Cilostazol)

Snippet

Sponsor: Gyeongsang National University Hospital | Conditions: Coronary Artery Disease, Percutaneous Coronary Intervention | Phase 4 | Status: COMPLETED